Patients with advanced ovarian cancer have paid about 41 million won per person yearly in drug costs. However, the new health insurance application will reduce the cost to 2.05 million won (with a 5 percent copayment). “We expect to support the stable supply of therapeutic drugs through the ...
O'Connell said officials have been actively planning for the end of their supply of free Paxlovid, which would mean Pfizer's drug would switch tothe commercial market. That means Americans' access to the drug would now become the same as other medications that require navigating insurance and ...
used the drug less often. Without no-cost test-to-treat options,residents have struggledto get prescriptions even though the drug itself is still free.